共 50 条
Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention
被引:0
|作者:
Stein, Elliot J.
[1
,2
]
Mesenbring, Elise
[3
]
Smith, Tracy
[3
]
Hebbe, Annika
[3
]
Salahuddin, Taufiq
[1
,2
]
Waldo, Stephen W.
[3
,4
]
Dyal, Michael D.
[5
,6
]
Doll, Jacob A.
[1
,2
,3
]
机构:
[1] Univ Washington, Med Ctr, Dept Med, Div Cardiol, Seattle, WA USA
[2] VA Puget Sound Healthcare Syst, Seattle, WA USA
[3] Vet Adm Clin Assessment Reporting & Tracking Progr, Off Qual & Patient Safety, Washington, DC USA
[4] Rocky Mt Reg VA Med Syst Vet Adm, Dept Med, Div Cardiol, Denver, CO USA
[5] Univ Miami, Miller Sch Med, Div Cardiol, Dept Med, Miami, FL USA
[6] Bruce W Carter Vet Adm, Miami, FL USA
基金:
美国国家卫生研究院;
关键词:
hospitals;
percutaneous coronary intervention;
quality improvement;
tomography;
optical coherence;
United States;
OUTCOMES;
ULTRASOUND;
GUIDANCE;
QUALITY;
THERAPY;
D O I:
10.1161/CIRCINTERVENTIONS.124.014528
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUND:Intravascular imaging (IVI) is widely recognized to improve outcomes after percutaneous coronary intervention (PCI). However, IVI is underutilized and is not yet established as a performance measure for quality PCI. METHODS:We examined temporal trends of IVI use for all PCIs performed at Veterans Affairs hospitals in the United States from 2010 to 2022 using retrospective observational cohorts. IVI was defined as intravascular ultrasound or optical coherence tomography. A contemporary subset of PCIs from 2020 to 2022 was used to examine clinical characteristics associated with IVI use and test the reliability of IVI as a pass/fail performance measure. We then used a generalized linear mixed model to estimate the proportion of IVI use variability attributable to the hospital, physician, and patient level. Cox proportional hazard models were used to assess the association of IVI with clinical outcomes at 1 year. RESULTS:IVI use increased from 12.3% in 2010 to 43.1% in 2022 in 136 071 PCIs included in the study. Among 22 918 PCIs in the contemporary cohort, IVI was more frequent with nonemergent presentations, chronic total occlusions, and left main lesions but usage variability was primarily attributable to hospital (54%) and physician (33%) levels. As a pass/fail performance measure, reliability was high (>0.96) at hospital and physician levels. However, IVI use was not associated with statistically significant differences in mortality or major adverse cardiovascular events in this cohort. CONCLUSIONS:IVI use for PCI is increasing rapidly at Veterans Affairs hospitals in the United States but with marked variation at the hospital and physician levels. IVI meets established criteria for an effective performance measure and should be measured and reported by local and national organizations to encourage further uptake. Ongoing training and quality improvement may be required to maximize the benefit of IVI as it is more widely utilized.
引用
收藏
页数:9
相关论文